National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

therapeutic progesterone
A synthetic form of the endogenous hormone progesterone. Progesterone binds to the progesterone receptor, resulting in dissociation of heat shock proteins, receptor phosphorylation, and transcription activation through direct or indirect interaction with transcription factors. This agent exerts inhibitory effects on estrogens by decreasing the number of estrogen receptors and increasing its metabolism to inactive metabolites. Progesterone induces secretory changes in the endometrium, decreases uterine contractility during pregnancy, and maintains pregnancy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:progesterone
US brand names:Colprosterone
Gesterol 100
Lipo-Lutin
Lucorteum Sol
Luteohormone
Progestin
Prolutin
Foreign brand names:Corlutina
Corluvite
Cyclogest
Gestiron
Gestone
Lutocyclin
Lutocylin
Lutocylin M
Lutogyl
Lutromone
Progestasert
Progesterol
Progestogel
Progestol
Progeston
Prolidon
Syngesterone
Utrogestan
Abbreviation:PRG
Chemical structure name:delta4-pregnene-3,20-dione



Previous:therapeutic estradiol, therapeutic hemin, therapeutic hydrocortisone, therapeutic immune globulin, therapeutic melatonin
Next:therapeutic testosterone, therapeutic triiodothyronine, therapeutic tumor infiltrating lymphocytes, TheraSphere, ThermoDox

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov